4Filed Sep 9, 8:00 PM ET

Transcat (TRNS) Director Cynthia Langston Converts RSUs, Sells 1,587 Shares

$TRNS · TRANSCAT INC

Research Summary

AI-generated summary of this SEC filing

Updated

Transcat (TRNS) Director Cynthia Langston Converts RSUs, Sells 1,587 Shares

What Happened
Cynthia Langston, a director of Transcat, had a grant of 1,671 restricted stock units (RSUs) on 2026-09-09 and on 2026-09-10 converted/exercised 1,587 vested RSUs into common shares. The Form 4 reports the exercise/conversion at $0.00 per share (RSU conversion) and shows 1,587 shares were disposed the same day. The filing reports $0 consideration for the derivative entries (reflecting RSU conversion), and does not state market proceeds or the cash amount received on the disposition.

Key Details

  • Transaction dates: RSU grant (A) 2026-09-09; conversion/exercise (M) and same-day disposition 2026-09-10.
  • Reported price: $0.00 per share for the derivative conversion entries (standard for RSU-to-stock conversions).
  • Shares involved: 1,671 RSUs granted (derivative); 1,587 RSUs vested/converted and 1,587 shares disposed same day.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Notable footnotes:
    • F1: RSUs convert into common stock one-for-one.
    • F2: The 1,671 RSU grant was made in a Rule 16b‑3 exempt transaction and (unless otherwise provided) vests on 2027-09-09.
    • F3: The RSUs that converted on 2026-09-10 had vested on that date.
    • F4: (Related option vesting schedule noted in filing).
  • Timeliness: Form 4 was filed 2026-09-10 for transactions on 9/9–9/10/2026 (filed within the standard two-business-day window).

Context
RSUs are compensation awards that convert to common shares one-for-one when they vest; the $0.00 line items reflect that conversion rather than a market purchase. The converted 1,587 shares were disposed the same day — filings that show immediate disposition after vesting are commonly net settlements or sales-to-cover tax withholding, but the form does not specify the reason. This activity appears to be routine equity compensation/settlement by a director rather than an open-market purchase.